Medical News Today -
15 Dec 2013 10:00
Johns Hopkins researchers say that a drug approved to treat lung cancer substantially shrank tumors in mice that were caused by a rare form of bone cancer called chordoma.Reporting in the journal PLOS ONE, the researchers say the finding offers hope to chordoma patients, who have no treatment options once surgery and radiation have been exhausted. There are no U.S. Food and Drug Administration-approved medications for the disease and, because its incidence is only one in 1 million, there is litt...
Share this Article